Generic for Minocin: Minocycline

Yes. The generic name for Minocin is minocycline. 6 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 5 of the 7 Minocin products the Orange Book lists.

Run it in Rivvi

Map Minocin and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Minocin products in the Orange Book

Minocin products and approved generics
Form and route	Strength	Brand status	Brand TE	Active generics	Generic TE codes
capsule, oral	EQ 100MG BASE	Marketed (Rx)	AB	5	AB
capsule, oral	EQ 100MG BASE	Discontinued	None	5	AB
capsule, oral	EQ 50MG BASE	Marketed (Rx)	AB	5	AB
capsule, oral	EQ 50MG BASE	Discontinued	None	5	AB
capsule, oral	EQ 75MG BASE	Discontinued	None	5	AB
injectable, injection	EQ 100MG BASE/VIAL	Marketed (Rx)	None	0	None
suspension, oral	EQ 50MG BASE/5ML	Discontinued	None	0	None

NDA 050649, 050315, 050444, 050445, held by BAUSCH HEALTH US LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Approved generic minocycline

Approved generic versions of Minocin
Company	ANDA	TE code	Approved	Strengths
WATSON LABORATORIES INC	063065	AB (A-rated, therapeutically equivalent)	December 30, 1991	EQ 100MG BASE, EQ 100MG BASE, EQ 75MG BASE
WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC	063181	AB (A-rated, therapeutically equivalent)	December 30, 1991	EQ 50MG BASE, EQ 50MG BASE
ZYDUS WORLDWIDE DMCC	063009	AB (A-rated, therapeutically equivalent)	March 2, 1992	EQ 100MG BASE, EQ 100MG BASE, EQ 75MG BASE
ZYDUS WORLDWIDE DMCC	063011	AB (A-rated, therapeutically equivalent)	March 2, 1992	EQ 50MG BASE, EQ 50MG BASE
IMPAX LABORATORIES INC	065005	AB (A-rated, therapeutically equivalent)	March 23, 1999	EQ 100MG BASE, EQ 100MG BASE, EQ 50MG BASE, EQ 50MG BASE, EQ 75MG BASE
TORRENT PHARMACEUTICALS LTD	065062	AB (A-rated, therapeutically equivalent)	November 30, 2000	EQ 100MG BASE, EQ 100MG BASE, EQ 50MG BASE, EQ 50MG BASE, EQ 75MG BASE
AUROBINDO PHARMA LTD	065470	AB (A-rated, therapeutically equivalent)	March 11, 2008	EQ 100MG BASE, EQ 100MG BASE, EQ 50MG BASE, EQ 50MG BASE, EQ 75MG BASE

Minocin patents

Patents listed for Minocin
Patent	Expires	Covers	Use code	NDA
9084802	May 12, 2031	Method of use	U-282	050444
9278105	May 12, 2031	Method of use	U-282	050444
12161656	May 12, 2031	Drug product	None	050444
11944634	October 16, 2032	Drug product	None	050444

Minocin NDC codes

70842-160

Questions

Is there a generic for Minocin?

Yes. The generic name for Minocin is minocycline. 6 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 5 of the 7 Minocin products the Orange Book lists.

What is the generic name for Minocin?

The active ingredient in Minocin is minocycline, per the FDA Orange Book.

When does the Minocin patent expire?

The last patent listed for Minocin in the Orange Book expires October 16, 2032. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

Generic for Minocin